Structural basis for selective small molecule kinase inhibition of activated c-Met.
Rickert, K.W., Patel, S.B., Allison, T.J., Byrne, N.J., Darke, P.L., Ford, R.E., Guerin, D.J., Hall, D.L., Kornienko, M., Lu, J., Munshi, S.K., Reid, J.C., Shipman, J.M., Stanton, E.F., Wilson, K.J., Young, J.R., Soisson, S.M., Lumb, K.J.(2011) J Biol Chem 286: 11218-11225
- PubMed: 21247903 
- DOI: 10.1074/jbc.M110.204404
- Primary Citation of Related Structures:  
3R7O, 3Q6U, 3Q6W - PubMed Abstract: 
The receptor tyrosine kinase c-Met is implicated in oncogenesis and is the target for several small molecule and biologic agents in clinical trials for the treatment of cancer. Binding of the hepatocyte growth factor to the cell surface receptor of c-Met induces activation via autophosphorylation of the kinase domain ...